Once-Weekly 1.6mg/m2 Bortezomib BCD Regimen in Newly Diagnosed Multiple Myeloma: Better Response and Lower Incidence of Peripheral Neuropathy

被引：0
|
作者：
Li, Fangfang [1 ]
Li, Hao [1 ]
Li, Yubin [1 ]
Zhan, Zhumei [1 ]
Song, Wangshan [1 ]
Li, Fanglin [1 ]
Li, Xiangxin [1 ]
Wang, Lingling [1 ]
Wang, Yan [1 ]
Wang, Luqun [1 ]
机构：
[1] Shandong Univ, Dept Hematol, Qilu Hosp, Jinan, Shandong, Peoples R China
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
bortezomib; complete response; Multiple myeloma;
D O I：
10.1016/j.clml.2019.09.351
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-025
引用
收藏
页码：E211 / E211
页数：1
相关论文
共 31 条
  • [1] Once-Weekly 1.6 mg/m2 Bortezomib BCD Regimen in Elderly Patients with Newly Diagnosed Multiple Myeloma Who are Unfit for Standard Dose Chemotherapy
    Tang, Yong
    Yu, Ye-hua
    Yao, Yi-yun
    Zou, Li-fang
    Dou, Hong-ju
    Wang, Lei
    Zhu, Qi
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2017, 33 (01) : 22 - 30
  • [2] Once-Weekly 1.6 mg/m2 Bortezomib BCD Regimen in Elderly Patients with Newly Diagnosed Multiple Myeloma Who are Unfit for Standard Dose Chemotherapy
    Yong Tang
    Ye-hua Yu
    Yi-yun Yao
    Li-fang Zou
    Hong-ju Dou
    Lei Wang
    Qi Zhu
    Indian Journal of Hematology and Blood Transfusion, 2017, 33 : 22 - 30
  • [3] Bortezomib: Once-Weekly 1.6mg/m2 Maybe a Better Choice Compared with Twice-Weekly 1.3mg/m2 in Newly Dignosed Multiple Myeloma
    Li, Yubin
    Li, Fangfang
    Song, Wangshan
    Zhan, Zhumei
    Li, Xiangxin
    Wang, Lingling
    Li, Fanglin
    Hou, Ming
    Li, Hao
    Wang, Luqun
    BLOOD, 2019, 134
  • [4] Once-weekly bortezomib had similar effectiveness and lower thrombocytopenia occurrence compared with twice-weekly bortezomib regimen in treating patients with newly diagnosed multiple myeloma in China
    Yao, Rongxin
    Hu, Xudong
    Zhou, Shuping
    Zhang, Qianying
    Huang, He
    Sun, Ni
    Guo, Wenjian
    Yu, Kang
    Lin, Ying
    MEDICINE, 2019, 98 (39)
  • [5] Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
    Hoff, Fieke W.
    Banerjee, Rahul
    Khan, Adeel M.
    McCaughan, Georgia
    Wang, Bo
    Wang, Xiaoliang
    Roose, James
    Anderson Jr, Larry D.
    Cowan, Andrew J.
    Rajkumar, S. Vincent
    Kaur, Gurbakhash
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [6] Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
    Fieke W. Hoff
    Rahul Banerjee
    Adeel M. Khan
    Georgia McCaughan
    Bo Wang
    Xiaoliang Wang
    James Roose
    Larry D. Anderson
    Andrew J. Cowan
    S. Vincent Rajkumar
    Gurbakhash Kaur
    Blood Cancer Journal, 14
  • [7] Once-weekly (70 mg/m2) versus twice weekly (56 mg/m2) dosing of carfilzomib (CFZ) for patients (pts) with relapsed and/or refractory multiple myeloma (RRMM).
    Moreau, Philippe
    Stewart, A. Keith
    Dimopoulos, Meletios A.
    Siegel, David Samuel DiCapua
    Facon, Thierry
    Berenson, James R.
    Raje, Noopur S.
    Berdeja, Jesus G.
    Orlowski, Robert Z.
    Yang, Hui
    Ma, Haijun
    Karina Klippel, Zandra
    Zahlten-Kumeli, Anita
    Mezzi, Khalid
    Iskander, Karim
    Mateos, Maria-Victoria
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Development of Bortezomib Induced Peripheral Neuropathy (BiPN) In Multiple Myeloma: Incidence and Molecular Characterization In Newly Diagnosed Patients Treated with Bortezomib
    Broyl, Annemiek
    Corthals, Sophie
    Jongen, Joost L. M.
    van der Holt, Bronno
    Kuiper, Rowan
    de Knegt, Yvonne
    el Jarari, Laila
    Bertsch, Uta
    Lokhorst, Henk
    Durie, Brian G. M.
    Goldschmidt, Hartmut
    Sonneveld, Pieter
    BLOOD, 2010, 116 (21) : 138 - 138
  • [9] Impact of Body Mass Index on the Incidence of Bortezomib-induced Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma
    Moore, Donald C.
    Ringley, J. Tanner
    Nix, David
    Muslimani, Ala'a
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (03): : 168 - 173
  • [10] Impact of Body Mass Index (BMI) on the Incidence of Bortezomib -Induced Peripheral Neuropathy (BIPN) in Patients with Newly Diagnosed Multiple Myeloma (MM)
    Muslimani, Ala'a
    Moore, Donald C.
    Ringley, Tanner
    Robinson, Myra M.
    BLOOD, 2018, 132
1234